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Functional studies of a chimeric CXCR2/Gai2 protein 
Lori Rhoten 
The University of Tennessee-Knoxville 
Dept. of Biochemistry, Cellular, and Molecular Biology 
Abstract: 
As transmembrane proteins, chemokine receptors possess a large hydrophobic 
portion that is unstable in water and does not fold into the proper conformation in an 
aqueous environment. Consequently, it is difficult to isolate these receptor proteins in 
order to perform structural studies on them. However, it is believed that a fusion protein 
of the receptor connected to the alpha subunit of the G protein would stabilize the C-
terminus side of the receptor since the G-protein is soluble in water. Similarly, the 
addition of ligand would do the same on the N-terminus side of the protein. This would 
increase the solubility of the receptor protein and hopefully confer enough stability to 
secure it in its natural confirmation. Here, a fusion protein of the receptor and alpha 
subunit is produced. Using transfected HEK 293 cells, the fusion protein is shown to be 
expressed on the cell surface. 
Introduction: 
Chemokines are small, pro-inflammatory protein signals that induce rapid, 
directed chemotaxis in phagocytes and T cells toward sites of physical damage by 
bacteria, viruses, and other destructive agents4. In addition to increased cell motility, 
interaction of chemokines with receptor cells produces changes in cell shape, generation 
of superoxide anions, and release of enzymes3. The result of this is a general 
inflammatory response from phagocytic cells followed by a specific immune response 
from T cells 4. 
The large superfamily of chemokines, approximately 40 proteins, is subdivided 
into four groups: C-, CC-, CXC-, and CX3C},4. These divisions are based on differences 
in the number and arrangement of the first four conserved cysteine residues in the amino 
acid sequence 3. For example, the C-group has only one pair of cysteine residues, while 
the other three groups have two pairs5. Furthermore, the CXC- and CX3C-groups have 
cysteine pairs separated by one and three variable amino acids, respectively5. 
The activity of chemokines is mediated by their receptors, which are membrane-
spanning G-protein coupled receptors (GPCR). Like other transmembrane proteins, they 
have seven alpha-helical transmembrane domains connected by six loops, three 
intracellular and three extracellula? The N-terminus is extracellular, binds ligand, is 
slightly acidic, and has N-linked glycosylation sites3. Conversely, the C-terminus is 
intracellular, interacts with heterotrimeric G-proteins, and has regulatory phosphorylation 
sites on threonine and serine residues3. Extracellular loops 1 and 2 are connected by a 
disulfide bond between conserved cysteine residues, and intracellular loop 3 may also 
interact with the G-proteins2,3. 
Upon binding of ligand, a conformational change in the receptor induces an 
exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) by the alpha 
subunit of the G-protein, leading to dissociation of the alpha subunit from the beta-
gamma subunit complex2• Exchange of GDP for GTP can be eliminated through a 
mutation that replaces an arginine residue with a histidine 1• The beta subunit then 
activates phospholipase C, which catalyzes the hydrolysis of phosphotidylinosital-4,5-
diphosphate (PIP2) to inositoll ,4,5-triphosphate (lP3) and diacyl-glycerol (DAG)3. IP3 
leads to the release of calcium ions from intracellular strores which then interact with 
DAG to activate protein kinase C (PKci. Activation ofPKC leads to phosphorylation of 
other proteins and further cellular responses3• Simultaneously, the activated alpha 
subunit leads to MAP kinase activation and down-regulation of the receptor by 
phosphorylation of C-terminus serine and threonine residues3• Following this, the 
chemokine is degraded intracellularly and the activated receptor is returned to the plasma 
membrane3. This desensitization is important in maintaining the ability to sense a 
chemical gradiene. 
CXCR2 is a chemokine receptor found on granulocytes, monocytes, and mast 
cells and on some T cells and natural killer cells3• Its ligands include interleukin-8 (IL-
8), one of the most studied chemokines, and all CXC-group chemokines with the N-
terminal Glu-Leu-Arg (ELR) motif',4. It is associated with the inhibitory form of the G-
protein alpha subunit (Gai2i. Expression ofCXCR2 on neutrophils can be down-
regulated by tumor necrosis factor and lipopolysaccharide and increased by granulocyte-
colony-stimulating factor3• 
Methods: 
DNA encoding the genes for CXCR2 and Gai2 were amplified separately using 
polymerase chain reaction (PCR) with Ex Taq Polymerase. For CXCR2, the forward and 
reverse primers were hCXCR2 Not! (For) (5'-
GCGGCCGCATGGAAGA TTTT AACATGG-3') and hCXCR2-mut (Rev) (5'-
CTCCCCGGGGAGAGTAGTGGAAGTGTGC-3'), and for Gai2, they were Smal-Gia2 
(Forward) (5' -CCCGGGATGGGCTGCACCGTGAGCGCCG-3' and Gia2-Apal 
(Reverse) (5'-GGGGCCCTCAGAAGAGGCCGCAGTCCTT-3'). The products were 
run on a 1 % agarose gel, and the bands corresponding to 1 kb were extracted using 
QIAquick Gel Extraction Kit. 
Both CXCR2 and Gai2 DNA were then digested overnight at 37° C with Xmal 
restriction enzyme to create complimentary sticky ends at the end of CXCR2 and the 
beginning of Gai2. Each was cleaned up with QIAquick PCR Purification Kit, and equal 
amounts of DNA from each were ligated with T4 DNA ligase at room temperature 
overnight. PCR was then used amplify the ligated DNA using the forward CXCR2 
primer and the reverse Gail primer, and the band at 2 kb on a 1 % agarose gel was 
extracted using QIAquick Gel Extraction Kit. This DNA was ligated into the pEXP5-
CTITOPO® vector using the Invitrogen TA Expression Kit and used to transform One 
Shot® TOP 1 0 Competent E. coli cells. PCR screening confirmed the presence of the 
insert, and plasmid was isolated with Promega's Wizard Plus SV Minipreps DNA 
Purification System. 
PCR was done on the fusion DNA to introduce a HindIII site at the beginning of 
CXCR2 and aXbaI site at the end of Gai2. The forward primer CXCR2 Hind III For was 
obtained from Dr. Tom Masi in the Sparer Lab, and the reverse primer was Gia2Xba2 
(5'-CTAGTCTAGACTAGTCAGAAGAGG-3'). This DNA was ligated into the same 
vector as before and transformed One Shot® TOP 1 0 Competent E. coli cells. Plasmids 
from colonies showing the insert through PCR screening were isolated as before and 
digested overnight at 37°C with HindIII and Xbal. Gel extraction isolated the insert, 
which was then ligated into the pRc/CMV vector by T 4 DNA ligase with a 40: 1 molar 
ratio of insert to vector. This reaction was incubated overnight in a water bath at 4°C. 1 
~l of the ligation reaction was then used to transform DH5a cells; colonies were screened 
by digestion with HindIII and XbaI. 
This plasmid was used to transfect HEK 293 cells. A 6-well dish was plated with 
2.0 x 105 cells per well two days before transfecting. GFP was used as a positive control, 
and untransfected HEK 293 cells were a negative control. The transfected cells were 
harvested from the wells and used for Fluorescent Activated Cell Sorting (F ACS) by 
applying a fluorescent antibody specific for CXCR2. Some of the transfected cells were 
kept in T150 flasks in complete DMEM media with G418 antibiotic to create a stable line 
oftransfectants. These stables were also analyzed by FACS one month after transfection; 
and some were frozen in 10% DMSO. Mutagenesis was also performed on the fusion 
DNA to introduce the R21 OH mutation in Gai2. This was done using PCR with Pfu Ultra 
Polymerase and primers GaiR210Hl (5'- CAG CGG TCT GAG CAC AAG AAG TGG 
ATC -3') and GaiR210H2 (5'- GAT CCA CTT CTT GTG CTC AGA CCG CTG -3') to 
change the existing CGG codon to CAC. Both mutant and wild type fusion DNA were 
used to transfect HEK 293 cells to create stable cell lines. In collaboration with Dr. 
Becker's lab, the wild type CXCR2/Gai2 plasmid is being used to transform yeast cells. 
Results: 
Sequencing from the Molecular Biology Resource Facility confirmed the 
CXCR2/Gai2 insert ligated into the TOPO vector in the correct orientation with CXCR2 
proceeding Gai2. Since the insert was approximately 2 kb, a third primer obtained from 
Dr. Sparer's lab was used to sequence the region where the two ligated together. This 
confmned neither CXCR2 nor Gai2 were mutated during ligation. Sequencing also 
confirmed the presence of the insert in the correct orientation in the pRc/CMV vector. 
Transfection efficiency was done by analyzing GFP fluorescence one day after 
transfection. In each case, approximately 80% of the cells transfected showed GFP 
expression. For F ACS analysis, a gate was set to include only cells which were a certain 
size so as to eliminate cell debris from being counted (Figure 1). The first 30,000 cells to 
fit this criterion were counted and analyzed. Using the untransfected HEK 293 as 
background, approximately 10% and 3% of the transient and stable wild-type 
transfectants, respectively, expressed more CXCR2 than normal (Figure 2). By analyzing 
fluorescence of antibodies bound to receptors on the cell surface, this confirmed not only 
the production of a fusion protein, but also its location on the plasma membrane. F ACS 
analysis for the mutant CXCR2/Gai2 protein has not yet been performed. 
Discussion: 
The work presented here provides evidence that a chemokine receptor fused to its 
associated G-protein alpha subunit can be expressed on mammalian plasma membranes. 
However, more transient cells expressed the fusion protein than observed in the stable 
line. This is thought to occur because fusion of the receptor to the G-protein has created 
a constitutively active receptor that is down-regulated by the cell. In order to test this 
theory, the R21 OH mutation was made to inactivate the fusion Gai2 subunit, but data is 
not yet available to confirm or reject this hypothesis. The production of fusion 
CXCR2/Gai2 protein on cell surfaces provides opportunity for further experiments to test 
its functionality through binding and signaling assays with commercially available 
ligands such as IL-8 or gro-a.. Comparison of fusion K<t and Bmax values to those for 
wild-type CXCR2 will show if Gai2 in some way altered the ability of CXCR2 to bind its 
ligands. Observation of calcium flux or other downstream signaling effects, such as 
phosphorylation of other proteins, will determine if the fusion protein can still participate 
in signal transduction. 
For biophysical studies, large quantities of protein are needed, but since CXCR2 
is a mammalian protein, this cannot be obtained using a bacterial system such as E. coli. 
At first, HEK 293 cells were to be used to isolate the protein, but these proved difficult to 
grow in suspension. Media without calcium was used to prevent attachment, but the cells 
died, became contaminated, or simply did not grow. Yeast cells, as a eukaryotic system, 
can express wild-type CXCR2, so they are to be used produce the fusion protein in large 
amounts. The correct plasmid, however, has yet to be produced from the in vivo ligation 
reaction of yeast. 
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Figure 1: Gated regions for countable cells outlined in black. (a) Transient transfectants 
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Figure 2: F ACS data graphed as fluorescent counts versus number of cells. In both, the 
black line is background fluorescence from untransfected 293 cells. (a) Transient cells. 
Pink and Green lines are transfections done by Lori and Tom, respectively, at the same 
time. Approximatey 10% of transfected cells show more expression than nonnal cells. (b) 
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